Chemed EBIT 2010-2024 | CHE

Chemed annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Chemed EBIT for the quarter ending September 30, 2024 was $0.092B, a 6.11% increase year-over-year.
  • Chemed EBIT for the twelve months ending September 30, 2024 was $0.364B, a 17.23% increase year-over-year.
  • Chemed 2023 annual EBIT was $0.341B, a 0.85% decline from 2022.
  • Chemed 2022 annual EBIT was $0.343B, a 0.13% increase from 2021.
  • Chemed 2021 annual EBIT was $0.343B, a 11.97% decline from 2020.
Chemed Annual EBIT
(Millions of US $)
2023 $341
2022 $343
2021 $343
2020 $390
2019 $257
2018 $244
2017 $113
2016 $179
2015 $184
2014 $168
2013 $133
2012 $156
2011 $154
2010 $144
2009 $126
Chemed Quarterly EBIT
(Millions of US $)
2024-09-30 $92
2024-06-30 $88
2024-03-31 $72
2023-12-31 $111
2023-09-30 $87
2023-06-30 $70
2023-03-31 $73
2022-12-31 $81
2022-09-30 $81
2022-06-30 $92
2022-03-31 $89
2021-12-31 $98
2021-09-30 $93
2021-06-30 $72
2021-03-31 $80
2020-12-31 $143
2020-09-30 $74
2020-06-30 $93
2020-03-31 $79
2019-12-31 $77
2019-09-30 $65
2019-06-30 $66
2019-03-31 $49
2018-12-31 $67
2018-09-30 $62
2018-06-30 $58
2018-03-31 $56
2017-12-31 $57
2017-09-30 $54
2017-06-30 $-39
2017-03-31 $41
2016-12-31 $53
2016-09-30 $43
2016-06-30 $38
2016-03-31 $44
2015-12-31 $49
2015-09-30 $50
2015-06-30 $45
2015-03-31 $41
2014-12-31 $50
2014-09-30 $40
2014-06-30 $42
2014-03-31 $37
2013-12-31 $39
2013-09-30 $29
2013-06-30 $26
2013-03-31 $39
2012-12-31 $46
2012-09-30 $36
2012-06-30 $40
2012-03-31 $35
2011-12-31 $46
2011-09-30 $41
2011-06-30 $36
2011-03-31 $31
2010-12-31 $38
2010-09-30 $37
2010-06-30 $34
2010-03-31 $34
2009-12-31 $31
2009-09-30 $33
2009-06-30 $28
2009-03-31 $35
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $7.853B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00